M. Bret Schneider
Corporate Officer/Principal bei Stanford University
Profil
M.
Bret Schneider was the founder of Cervel Neurotech, Inc. which was founded in 2008 where he held the title of Chief Medical Officer.
Currently, he is a Staff Scientist at Stanford University.
Dr. Schneider received his undergraduate degree from Washington University in St. Louis and his doctorate from Rush University.
Aktive Positionen von M. Bret Schneider
Unternehmen | Position | Beginn |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von M. Bret Schneider
Unternehmen | Position | Ende |
---|---|---|
Cervel Neurotech, Inc.
Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Gründer | - |
Ausbildung von M. Bret Schneider
Washington University in St. Louis | Undergraduate Degree |
Rush University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Cervel Neurotech, Inc.
Cervel Neurotech, Inc. Medical SpecialtiesHealth Technology Cervel Neurotech, Inc. develops and manufactures medical devices. It engages in the development of a non-invasive, non-pharmacologic and non-systemic treatment for psychiatric and neurologic illnesses. The firm’s Cervel Multicoil Steerable TMS technology is a new approach to an established technology, repetitive transcranial magnetic stimulation, designed to produce better outcomes and a more comfortable treatment for patients. The company was founded in 2008 by M. Bret Schneider, David J. Mishelevich and Michael Joseph Partsch and is headquartered in Redwood City, CA. | Health Technology |